CytomX Therapeutics, Inc.
CTMX
$2.03
$0.031.50%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.24% | -46.84% | -42.34% | -39.42% | -24.15% |
| Total Receivables | -32.65% | -85.16% | -9.59% | 38.57% | 45.82% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 49.38% | 26.41% | -28.35% | -30.70% | -38.04% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 15.06% | -48.20% | -41.34% | -38.28% | -23.81% |
|
|
|||||
| Total Current Assets | 15.06% | -48.20% | -41.34% | -38.28% | -23.81% |
| Net Property, Plant & Equipment | -41.71% | -37.27% | -34.46% | -29.63% | -27.30% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -22.26% | -21.07% | -20.03% | -19.06% | -18.20% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.16% | 9.23% | 9.30% | 9.26% | -1.49% |
| Total Assets | 9.95% | -46.67% | -40.27% | -37.16% | -23.89% |
|
|
|||||
| Total Accounts Payable | -62.85% | -85.95% | -25.38% | -16.60% | -40.62% |
| Total Accrued Expenses | -16.73% | -25.80% | -29.89% | 3.15% | -13.29% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.97% | 12.04% | 12.12% | 12.18% | 12.26% |
| Total Finance Division Other Current Liabilities | -82.05% | -72.43% | -49.19% | -22.78% | 2.87% |
| Total Other Current Liabilities | -82.05% | -72.43% | -49.19% | -22.78% | 2.87% |
| Total Current Liabilities | -72.54% | -65.27% | -44.99% | -18.78% | 1.05% |
|
|
|||||
| Total Current Liabilities | -72.54% | -65.27% | -44.99% | -18.78% | 1.05% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -79.06% | -64.95% | -54.82% | -47.19% | -41.38% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -64.42% | -67.98% | -63.10% | -67.30% | -71.15% |
| Total Liabilities | -71.04% | -66.05% | -51.46% | -40.37% | -35.27% |
|
|
|||||
| Common Stock & APIC | 15.05% | 2.23% | 2.25% | 2.06% | 6.66% |
| Retained Earnings | 6.70% | 5.86% | 4.41% | 1.91% | 1.52% |
| Treasury Stock & Other | 925.00% | 90.00% | -71.58% | 163.49% | -111.43% |
| Total Common Equity | 483.99% | 179.07% | 99.04% | 54.23% | 63.27% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 483.99% | 179.07% | 99.04% | 54.23% | 63.27% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 483.99% | 179.07% | 99.04% | 54.23% | 63.27% |
|
|
|||||